ID

42996

Descrizione

Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609

collegamento

http://clinicaltrials.gov/ct2/show/record/NCT00661609

Keywords

  1. 18/11/11 18/11/11 -
  2. 26/03/14 26/03/14 - Martin Dugas
  3. 17/09/21 17/09/21 -
Caricato su

17 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility DRKS00004052 NCT00661609 Bladder Cancer

Eligibility Advanced Bladder Cancer NCT00661609

Inclusion criteria
Descrizione

Inclusion criteria

Alias
UMLS CUI-1
C1512693
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
Descrizione

Urothelial Neoplasm

Tipo di dati

boolean

Alias
UMLS CUI-1
C1519840
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
Descrizione

Stage IV

Tipo di dati

boolean

Alias
UMLS CUI-1
C0441772
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
Descrizione

Prior chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI-1
C1514457
Ambulatory and capable of all selfcare more than 50% of waking hours
Descrizione

General status

Tipo di dati

boolean

Alias
UMLS CUI-1
C0947124
Exclusion criteria
Descrizione

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
Descrizione

Prior treatment

Tipo di dati

boolean

Alias
UMLS CUI-1
C1514463
Inadequate bone marrow reserve
Descrizione

Inadequate bone marrow reserve

Tipo di dati

boolean

Alias
UMLS CUI-1
CL406855
Inadequate liver function in the presence of liver metastases
Descrizione

Liver Dysfunction

Tipo di dati

boolean

Alias
UMLS CUI-1
C0086565
Impaired renal function
Descrizione

Impaired renal function

Tipo di dati

boolean

Alias
UMLS CUI-1
C1565489

Similar models

Eligibility Advanced Bladder Cancer NCT00661609

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Urothelial Neoplasm
Item
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
boolean
C1519840 (UMLS CUI-1)
Stage IV
Item
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
boolean
C0441772 (UMLS CUI-1)
Prior chemotherapy
Item
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
boolean
C1514457 (UMLS CUI-1)
General status
Item
Ambulatory and capable of all selfcare more than 50% of waking hours
boolean
C0947124 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Prior treatment
Item
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
boolean
C1514463 (UMLS CUI-1)
Inadequate bone marrow reserve
Item
Inadequate bone marrow reserve
boolean
CL406855 (UMLS CUI-1)
Liver Dysfunction
Item
Inadequate liver function in the presence of liver metastases
boolean
C0086565 (UMLS CUI-1)
Impaired renal function
Item
Impaired renal function
boolean
C1565489 (UMLS CUI-1)

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial